Breast Imaging Market Overview and Analysis Report Forecast to 2027

1
Breast Imaging Market Demands, Overview,
Component, Market Revenue and Forecast
2027 Rising prevalence of tumors and cancers
among the women is encouraging the development of
a market for dealing with the issues faced by
them. The increasing population of females in
conjunction with rising healthcare expenditures
is expected to unleash developmental
opportunities to the markets dealing with the
health disorders found in women. Market Research
Future (MRFR) has published a study on the
global breast imaging market to assess its
prospects. The analysis reveals that the market
is projected to exhibit a CAGR of 8.5 during
the review period 2017 to 2023. Breast cancer is
one of the widely present cancers with a high
fatality rate. Around 200,000 new cases are
registered every year, as per stated by the World
Health Organization (WHO). This has encouraged
the leaders in the healthcare industry to
research develop advanced devices focused on
women health. It is projected to motivate the
growth trends in the breast imaging market over
the next few years. what is molecular breast
imaging? Breast imaging is gaining traction for
the assessment of tumors. Women are getting
increasingly aware of the health disorders which
has generated demand for early detection of
diseases. It is expected to revolutionize the
growth trajectory of the global breast imaging
market in the years to come. However, the stigma
associated with these diseases in developing
nations restricts women from accessing medical
facilities. This, in turn, is anticipated to
undermine market growth over the next few
years. Get Sample Report _at_ https//www.marketresea
rchfuture.com/sample_request/5612 Competitive
Dashboard The key players participating in the
share analysis of the global breast imaging
market are General Electric Company (U.K.),
Koninklijke Philips N.V. (Netherlands), Siemens
(Germany), Hologic, Inc. (U.S.), Dilon
Technologies, Inc. (U.S.), Fujifilm Holdings
Corporation (Japan), Aurora Imaging Technology,
Inc. (U.S.), Toshiba Corporation (Japan), Gamma
Medica, Inc. (U.S.), and Sonocine, Inc.
(U.S.). Market Segmentation By type, the global
breast imaging market has been segmented into
mammography, PET, CT, MRI, breast biopsy,
ultrasound, tactile imaging, and others. The
mammography segment is further sub-segmented
into film-screen mammography, 3D mammography,
Full-field digital mammography (FFDM),
scintimammography or molecular breast imaging,
and others. The breast biopsy has been sub-
segmented into image-guided breast biopsy,
ultrasound-guided core biopsy, tactic core
biopsy, and others. Based on application, the
breast imaging market has been segmented into
breast cancer diagnosis, metastatic axillary
adenocarcinoma, post-neoadjuvant chemotherapy,
and others. The breast imaging market, by end
user, has been segmented into diagnostic centers,
hospitals, and others. Regional Analysis
2
By region, the global breast imaging market has
been segmented into Americas, Asia Pacific,
Europe, and the Middle East Africa (MEA).
Americas is the largest market for breast
imaging. The region is burdened with the rising
patient population of breast cancer. On the other
hand, the technological advancements in the
healthcare sector of the region are skyrocketing.
Thus, a healthy growth trajectory has been
forecasted for the breast imaging market in the
region. Asia Pacific is witnessing developments
in healthcare technology, which is expected to
augment breast imaging market in the region. The
economic development in the region is likely to
have a positive influence on the growth trends
of the market in the forthcoming years. Industry
News In January 2019, QTbreasthealth, an
advanced imaging center, has announced the launch
of a New Breast Ultrasound Imaging Center in
Grand Rapids, Mich., featuring its QTscan
quantitative transmission ultrasound
technology. In October 2018, Royal Philips, a
Dutch multinational technology company
headquartered in Amsterdam, has introduced its
latest all-in-one breast imaging solution to be
used with use with its Epiq and Affiniti
ultrasound systems. In July 2018, The U.S. Food
and Drug Administration announced the approval
for a magnetic device system to guide lymph node
biopsies in patients who are suffering from
breast cancer and undergoing mastectomy. Browse
Full Report Details _at_ https//www.marketresearchfu
ture.com/reports/breast-imaging-
market-5612 About US Market Research Future
(MRFR), enable customers to unravel the
complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market
Research Consulting Services. Contact
us Market Research Future (part of Wantstats
Research and Media Private Limited), 99 Hudson
Street,5Th Floor, New York, New York
10013, United States of America More Related
Report Dietary Supplements in the age of
Personalized Nutrition Market Chronic Kidney
Disease Market Seborrheic Keratosis Market
Pediatric Vaccines Market Optical Coherence
Tomography Market
3
(No Transcript)